RELMADA THERAPEUTICS, INC. Inventory, Finished Goods, Gross
RELMADA THERAPEUTICS, INC. (RLMD) had Inventory, Finished Goods, Gross of $6.12 thousand as of 2014-02-28, per its 10-Q filed 2014-04-15.
Discontinued › Balance Sheet › Assets › Assets, Current
us-gaap:InventoryFinishedGoods · last filed 2014-04-15
- 2014-02-28: Inventory, Finished Goods, Gross $6.12K.
- 2013-11-30: Inventory, Finished Goods, Gross $4.73K.
- 2013-08-31: Inventory, Finished Goods, Gross $3.17K.
- 2013-05-31: Inventory, Finished Goods, Gross $2.37K.
| Period end | Inventory, Finished Goods, Gross |
|---|---|
| 2014-02-28 | $6.12K 10-Q · filed 2014-04-15 |
| 2013-11-30 | $4.73K 10-Q · filed 2014-01-13 |
| 2013-08-31 | $3.17K 10-Q · filed 2014-04-15 |
| 2013-05-31 | $2.37K 10-Q · filed 2013-07-12 |
| 2013-02-28 | $2.69K 10-Q · filed 2013-05-03 |
| 2012-08-31 | $6.41K 10-K · filed 2013-12-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Opus Genetics, Inc. (IRD) | United States | $0.406B | -3.16 |
| Arcturus Therapeutics Holdings Inc. (ARCT) | $0.402B | -2.05 | |
| GALECTIN THERAPEUTICS INC (GALT) | United States | $0.399B | -11.06 |
| ARS Pharmaceuticals, Inc. (SPRY) | United States | $0.414B | -3.70 |
| Atea Pharmaceuticals, Inc. (AVIR) | United States | $0.414B | -2.26 |
| Turn Therapeutics Inc. (TTRX) | United States | $0.397B | -25.68 |
| DiaMedica Therapeutics Inc. (DMAC) | United States | $0.423B | -10.11 |
| PROTHENA CORP PUBLIC LTD CO (PRTA) | Ireland | $0.428B | -11.53 |
| Rezolute, Inc. (RZLT) | United States | $0.382B | -6.45 |
| CYPHERPUNK TECHNOLOGIES INC. (CYPH) | United States | $0.438B | -75.63 |